Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-08MENS3Form 3 Filing: Initial Statement of Beneficial Ownership of Securities for Jyong Biotech Ltd.HIGH
This filing reports the initial beneficial ownership of securities for Jyong Biotech Ltd. (MENS) as of April 8, 2026. Fu-Feng Kuo, identified as the CEO and a 10% owner, has reported beneficial ownership of 25,349,500 ordinary shares. These shares are held indirectly through Perfect Minds Co., Ltd., a Seychelles compan...
Micro CapBiotechnology
2026-04-08Jyong Biotech Ltd.3Form 3 Filing: Initial Statement of Beneficial Ownership of Securities for Jyong Biotech Ltd.DuplicateHIGH
This filing reports the initial beneficial ownership of securities for Jyong Biotech Ltd. (MENS) as of April 8, 2026. Fu-Feng Kuo, identified as the CEO and a 10% owner, has reported beneficial ownership of 25,349,500 ordinary shares. These shares are held indirectly through Perfect Minds Co., Ltd., a Seychelles compan...
Micro CapBiotechnology
2026-04-08EXOZ3Form 3 Filing for Damien Perriman - EXOZYMES INC.
This document is a Form 3 filing for Damien Perriman, reporting ownership in EXOZYMES INC. (EXOZ). Perriman, identified by CIK 0002096714, is the Chief Commercial Officer of the company. The filing indicates that as of April 1, 2026, Perriman has no securities owned. The signature date is April 8, 2026. The filing is r...
Micro CapBiotechnology